Patient “X” was living high when he got ill. A course creator and director for an enterprise delivering transformational experiences, X thrived on his 100-hour work weeks. From the U.S. to lndia to Australia to Germany, he made his living making a difference with...
Difference-Maker Unlike FMS, SFPN has identifiable pathology, physiology, and causes, and thus is definitionally a disease. Oaklander et. Al. Dr. Anne Oaklander MD, PhD, is making a difference – maybe a very big difference in the lives of many. Making a...
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
Seeking to curb their misuse, the FDA has come down hard on opioid painkillers, restricting their use, and making it more difficult for some people in chronic pain to gain access to them. Some fibromyalgia patients and their doctors have, not surprisingly, rebelled at...
A real go-getter, Nathalie hiked, biked and even modeled prior to getting the flu from hell. She tried just about everything she could, and a three year course of Valcyte did help, but when she had to stop the Valcyte she was in real trouble. Reaching outside her...
Autism is one of the most treatment resistant conditions there are – which is why the results of Bob Naviaux’s small autism drug trial were so surprising. Despite the fact that only one dose of the drug was given, every autistic child posted a significant...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.